Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria

Area of Science:

• Genetics
• Oncology
• Dermatology

Background:

• Melanoma risk is influenced by genetic factors, with CDKN2A and CDK4 being established high-penetrance genes.
• Recent research suggests germline variants in the POT1 gene may play a role in familial melanoma.
• This study investigates the POT1 gene in a cohort of melanoma patients.

Purpose of the Study:

• To sequence the entire POT1 gene in melanoma patients and controls.
• To identify POT1 germline variants associated with melanoma risk, particularly in high-risk individuals.
• To evaluate the predicted pathogenicity of identified POT1 variants.

Main Methods:

• Whole gene sequencing of POT1 in 694 patients (163 multiple primary melanomas, 133 positive family history) and 398 controls (200 single primary melanoma, 198 non-melanoma).
• Classification of patients into high-risk melanoma groups based on clinical presentation.
• Utilized 10 prediction tools to assess the functional impact of identified variants.

Main Results:

• Identified 53 distinct POT1 variants, with 8 exclusively found in high-risk melanoma patients.
• Two non-synonymous variants, p.R80C and p.N300H, were detected in high-risk individuals.
• p.R80C was predicted as deleterious by 80% of tools, while p.N300H was predicted as neutral. A splice site variant and a 5-UTR variant were also identified in high-risk cases.

Conclusions:

• Melanoma-associated POT1 germline variants appear to be rare.
• Further research is needed to fully elucidate the role of POT1 in melanoma predisposition and its utility in genetic counseling.